CELCUITY INC. Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
CELCUITY INC. (CELC) reported Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs of $263.73 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts · last filed 2025-11-13
- CELCUITY INC. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2024-06-30 was $264.00K.
- CELCUITY INC. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2023-03-31 was $7.49K.
- CELCUITY INC. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2021-03-31 was $3.87K.
- CELCUITY INC. adjustments to additional paid in capital, stock issued, issuance costs for fiscal 2024 was $263.73K, a 57.06% decline from fiscal 2023.
- CELCUITY INC. adjustments to additional paid in capital, stock issued, issuance costs for fiscal 2023 was $614.21K, a 57.58% increase from fiscal 2022.
- CELCUITY INC. adjustments to additional paid in capital, stock issued, issuance costs for fiscal 2022 was $389.76K, a 9976.60% increase from fiscal 2021.
- CELCUITY INC. adjustments to additional paid in capital, stock issued, issuance costs for fiscal 2021 was $3.87K.
| Period end | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 3 month | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 3 month as first filed | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 12 month |
|---|---|---|---|
| 2024-12-31 | $263.73K 10-K · filed 2025-03-31 | ||
| 2024-06-30 | $264.00K 10-Q · filed 2025-11-13 | $263.73K 10-Q · filed 2024-08-14 | |
| 2023-12-31 | $614.21K 10-K · filed 2025-03-31 | ||
| 2023-03-31 | $7.49K 10-Q · filed 2023-11-13 | ||
| 2022-12-31 | $389.76K 10-K · filed 2024-03-27 | ||
| 2021-12-31 | $3.87K 10-K · filed 2023-03-23 | ||
| 2021-03-31 | $3.87K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |